
From the Co-Chairs, October 2026
October 14, 2026
Trial Results: ECOG-ACRIN Research Round-Up
November 19, 2026News in Brief, November 2026
ECOG-ACRIN Broadens Its Scientific Portfolio
At the Fall 2026 Group Meeting, the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) announced that the Brain Tumor Working Group was elevated to full committee status within the Therapeutic Studies Program. It is now the Brain Tumor Committee.
ECOG-ACRIN also announced the formation of two new scientific programs: Cancer Population Science and Cancer Interception. These join ECOG-ACRIN’s three established scientific programs: Therapeutic Studies, Biomarker Sciences, and Cancer Control and Outcomes.
Also at the meeting, the Group named the inaugural chairs of the two new programs:
Al B. Benson III, MD (Northwestern University/Robert H. Lurie Comprehensive Cancer Center), is chair of the Cancer Population Science Program, filling a new position
Christopher P. Comstock, MD (Columbia University/Columbia Radiology), is chair of the Cancer Interception Program, filling a new position
Numerous organizational changes occurred in light of the two new programs. Within the Cancer Control and Outcomes Program, the Patient-Reported Outcomes Working Group was elevated to full committee status. It is now the Patient-Reported Outcomes Committee. ECOG-ACRIN also established a new research core, the Patient-Reported Outcomes (PRO) Laboratory. The Health Promotion Committee and the Psychosocial Outcomes and Survivorship Committee grew out of the former Psychosocial Outcomes and Health Promotion Subcommittee.
The new Cancer Interception Program includes the existing Prevention, Screening, and Surveillance Committee and its Prevention Subcommittee.
Within the new Cancer Population Science Program, the Health Equity Committee is now the Clinical Trial Support Committee. It includes the Social Determinants of Health Subcommittee and the Adolescents and Young Adults (AYA) Subcommittee. The program also includes the established Geriatric Oncology Committee, Real World Data Committee, and Community Cancer Committee.
The Biomarker Sciences Program contains a new TAILORx Correlative Science Committee, under the Laboratory Science and Pathology Committee.
View the updated group-wide organization chart. Explore the scientific programs and learn about their research areas, committees, and leaders.
ECOG-ACRIN Names New Committee Leaders
Also at the recent Group Meeting, ECOG-ACRIN announced the following committee leadership appointments, which are now in effect:
- Jennifer Barsky Reese, PhD (Fox Chase Cancer Center), is chair of the Patient-Reported Outcomes Committee, succeeding John (Devin) Peipert, PhD
- David Cella, PhD (Northwestern University), is chair of the Patient-Reported Outcomes (PRO) Laboratory, filling a new position
- Ilana F. Gareen, PhD (Brown University), and Elyse R. Park, PhD (Harvard University/Massachusetts General Hospital), are co-chairs of the Health Promotion Committee, filling new positions
- David E. Gerber, MD (The University of Texas Southwestern/Harold C. Simmons Comprehensive Cancer Center), is co-chair of the Symptom Science and Treatment Toxicity Committee, succeeding Victor Chang, MD
- Laila A. Gharzai, MD (Northwestern University/Robert H. Lurie Comprehensive Cancer Center), is chair of the Symptom Science and Treatment Toxicity Committee, succeeding Sheetal M. Kircher, MD
- Sheetal M. Kircher, MD (Northwestern University/Robert H. Lurie Comprehensive Cancer Center), is a co-chair of the Cancer Care Delivery Research Committee, succeeding Dr. Benson
- Philip E. Lammers, MD (Baptist Memorial Health Care/Mid South NCORP Consortium), is a co-chair of the NCORP Advisory Committee, succeeding Dr. Benson
- Ranee Mehra, MD (University of Maryland/Marlene and Stewart Greenebaum Comprehensive Cancer Center), is chair of the Head and Neck Cancer Committee, succeeding Barbara A. Burtness, MD
- Mrinal S. Patnaik, MBBS (Mayo Clinic Cancer Center), is chair of the Clonal Hematopoiesis Subcommittee, succeeding Ross L. Levine, MD
- Joseph A. Sparano, MD (Mount Sinai Health System/The Tisch Cancer Institute), is chair of the TAILORx Correlative Science Steering Committee, filling a new position
Early-Career Investigators Receive Awards of Distinction
Two presenters from the 2026 Young Investigator Symposium received awards of distinction—an annual tradition. The awards were announced during the General Session of the Fall 2026 Group Meeting.
- Allison L. Matous, MD (Dartmouth College), won the distinction award for clinical research for her presentation, Assessment of Contralateral Breast Dose in Radiotherapy With Cherenkov Imaging
- Fangdi Sun, MD (Stanford University), secured the distinction award for translational research for her presentation, Comparing BamHI-W and Single-Copy EBNA1 DNA in Non-Endemic EBV-Positive Nasopharyngeal Carcinoma: A 13-Year Experience
EA8171 Prostate MRI Results Take the Stage at RSNA
The first findings from study EA8171, Multiparametric MRI (mpMRI) in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer, will be featured at the upcoming Radiological Society of North America (RSNA) 2026 Annual Meeting in Chicago and online. Rajan T. Gupta, MD (Duke University), will present the data in an oral scientific session on behalf of study co-chair Clare M.C. Tempany-Afdhal, MB (Brigham and Women's Hospital) and the EA8171 study team. Meeting attendees, mark your calendars for Dr. Gupta’s presentation on Sunday, November 29, 10:00–10:10 AM (Central Time).
EA8171 is one of the largest prospective, multicenter studies on the performance of the standardized PI-RADS v2.1 scoring framework for mpMRI. The results confirm its very strong diagnostic performance in the detection and characterization of clinically significant prostate cancer in men with newly diagnosed prostate cancer who are planning for surgery. Read a summary of the data in this Aunt Minnie article.
Multiple Breast Cancer Researchers Prepare for SABCS 2026
The public-private partnership between ECOG-ACRIN and Caris Life Sciences will be on full display at the upcoming San Antonio Breast Cancer Symposium, along with the FEATURE (EA1183), EAI142, and RxFINE-Low (EA1242) clinical trials. The meeting will take place December 8–11, 2026. The upcoming ECOG-ACRIN Guide to SABCS26 will circulate after November 23, when abstract contents are made public.
ECOG-ACRIN and PrECOG Plan for ASH 2026
Researchers affiliated with ECOG-ACRIN and PrECOG, LLC will be active at the 68th American Society of Hematology (ASH) Annual Meeting and Exposition, where they will present in-depth scientific analyses of various types of blood cancer. Together, these studies aim to enhance the precision and safety of treatments for hematologic malignancies. The meeting will take place December 12–15, 2026, in New Orleans. To learn more, access ECOG-ACRIN’s Guide to ASH 2026.
ASCO Is Now Accepting Abstracts for Its 2027 Annual Meeting
To ECOG-ACRIN Authors and Investigators: The American Society of Clinical Oncology (ASCO) is now accepting abstract submissions for its 2027 Annual Meeting, taking place June 4–8, 2027, at McCormick Place, Chicago, IL. ASCO’s submission deadline is Tuesday, January 26, 2027, at 11:59 PM EST. More information can be found at https://www.asco.org/annual-meeting/abstracts-presentations/submission-details/requirements.
The following are ECOG-ACRIN’s procedures for those preparing abstracts:
- Please notify the Publications Team as soon as possible at [email protected] that you intend to submit an abstract
- All draft abstracts of ECOG-ACRIN protocols or studies using ECOG-ACRIN data or samples must be submitted to [email protected] by Tuesday, January 12, 2027; this includes trial-in-progress (TIP) abstracts and late-breaking abstract (LBA) placeholders
- The ECOG-ACRIN submission deadline is firm and necessary to ensure sufficient time for the Publications Team to draft the authorship line, review the abstract, and forward it to the National Cancer Institute and relevant industry collaborators for a courtesy review
- Access publication and authorship guidelines on the members side of the website at https://www.ecog.org/ecoginst/Manuals.html
- Direct any questions regarding ECOG-ACRIN publication procedures to the Publications Team via email to [email protected]
Fall Group Meeting Session Recordings Are Now Available
Did you miss the Fall 2026 Group Meeting—or attend but miss some sessions you wanted to attend? If you are an ECOG-ACRIN member, you can now catch up on important study updates and trainings by viewing our library of session recordings.
- Attendees can simply visit the Attendee Hub Website and log in with the information provided during registration
- All other members should first register for the meeting and then visit the Attendee Hub Website and log in with the information provided during registration; navigate to ‘Schedule,’ and then select ‘On Demand’ from the dropdown list
Note: The Attendee Hub website will expire 90 days following the meeting (mid-January 2027).
ECOG-ACRIN to Launch Redesigned Members Website
In the coming months, ECOG-ACRIN will launch a redesigned Members Website with enhanced features and easier access to member resources and information. As part of this update, the way members log in to the site will change. Existing ecog.org member site usernames and passwords will be retired.
Members will be able to access the new site using the same ID.me credentials currently used for the ECOG-ACRIN Web Application Portal and the CTSU Website. The updated Members Website will utilize the NCI-CTEP Single Sign-On (SSO) federated authentication system, integrated with ID.me for identity proofing and multi-factor authentication (MFA).
For assistance with CTEP-IAM registration or linking your ID.me account, please visit the CTEP Login Help page.
![ECOG-ACRIN logo[19516]275×75](https://blog.ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
